Izrael - héber - Ministry of Health

taro international ltd, israel - doxorubicin hydrochloride - doxorubicin hydrochloride 2 mg / 1 ml - doxorubicin

Izrael - héber - Ministry of Health

j-c health care ltd - doxorubicin hydrochloride - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin

Izrael - héber - Ministry of Health

baxter healthcare distribution ltd., israel - doxorubicin hydrochloride - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin

Izrael - héber - Ministry of Health

beit-erez havat milatin ltd - spiramycin - תמיסה להזרקה - spiramycin 600000 iu/ml

Izrael - héber - Ministry of Health

salomon,levin & elstein ltd - epirubicin hydrochloride 2 mg / 1 ml - solution for injection / infusion - epirubicin - for the treatment of wide spectrum of neoplastic diseases, including:- breast carcinoma- lung carcinoma - high doses- ovarian carcinoma- gastric carcinomas- soft tissue sarcoma- i.v. administration for the treatment of advanced bladder carcinoma- intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection.

Izrael - héber - Ministry of Health

sanofi - aventis israel ltd - spiramycin 1.5 miu - film coated tablets - spiramycin - respiratory tract infections, infections caused by clamydia, cryptosporidiosis pregnancy toxoplasmosis.

Izrael - héber - Ministry of Health

pfizer pharmaceuticals israel ltd - doxorubicin hydrochloride 10 mg / 5 ml - solution for injection - doxorubicin - adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, hodgkin's lymphomas, neuroblastomas, wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

Izrael - héber - Ministry of Health

pfizer pharmaceuticals israel ltd - doxorubicin hydrochloride 50 mg / 25 ml - solution for injection - doxorubicin - adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, hodgkin's and non- hodgkin's lymphomas, neuroblastomas, wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

Izrael - héber - Ministry of Health

beit-erez havat milatin ltd - metronidazole; spiramycin - טבליה - metronidazole 125 mg; spiramycin 750000 iu

Izrael - héber - Ministry of Health

beit-erez havat milatin ltd - spiramycin 60 miu / 100 ml - solution for injection - for treatment of upper respiratory disease in the dry season for infections sensitive to spiramycin in cattle and sheep only.